Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.570
+0.030 (0.66%)
At close: Mar 9, 2026, 4:00 PM EDT
4.580
+0.010 (0.22%)
After-hours: Mar 9, 2026, 7:02 PM EDT
Strata Critical Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 41.35 | -27.31 | -56.08 | -27.26 | -36.92 | |
| Depreciation & Amortization | 6.9 | 3.26 | 7.11 | 5.73 | 1.17 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.07 | - | |
| Asset Writedown & Restructuring Costs | 2.71 | 5.76 | 20.75 | - | - | |
| Loss (Gain) From Sale of Investments | 5.2 | - | - | 2.16 | - | |
| Stock-Based Compensation | 17.83 | 19.89 | 12.5 | 8.28 | 11.28 | |
| Provision & Write-off of Bad Debts | - | - | 0.16 | - | - | |
| Other Operating Activities | -58.11 | -3.82 | -10.06 | -26.09 | 5.4 | |
| Change in Accounts Receivable | -12.03 | -1 | -10.25 | -5.35 | -1.74 | |
| Change in Accounts Payable | 2.38 | -8.34 | 9.05 | 9.9 | 2.52 | |
| Change in Unearned Revenue | 1.68 | -0.12 | 0.12 | 0.74 | 1.56 | |
| Change in Other Net Operating Assets | -1.11 | 6.45 | -5.65 | -5.31 | -4.9 | |
| Operating Cash Flow | -48.91 | -2.52 | -32.35 | -37.13 | -21.63 | |
| Capital Expenditures | -9.6 | -30.86 | -2.11 | -0.73 | -0.49 | |
| Sale of Property, Plant & Equipment | - | - | 0.14 | - | - | |
| Cash Acquisitions | -66.54 | -2.23 | - | -48.1 | -23.07 | |
| Divestitures | -2.81 | - | - | - | - | |
| Sale (Purchase) of Intangibles | -1.42 | -2.12 | - | - | -12.36 | |
| Investment in Securities | 150.11 | 34.2 | 19.06 | 128.17 | -280.26 | |
| Investing Cash Flow | 69.75 | -1.02 | 17.09 | 79.34 | -316.17 | |
| Total Debt Repaid | - | - | - | - | -1.17 | |
| Net Debt Issued (Repaid) | - | - | - | - | -1.17 | |
| Issuance of Common Stock | 0.19 | 0.17 | 0.07 | 0.09 | 335.04 | |
| Repurchase of Common Stock | -9.11 | -5.93 | -0.15 | -1.17 | -3.17 | |
| Financing Cash Flow | -8.91 | -5.76 | -0.08 | -1.08 | 330.7 | |
| Foreign Exchange Rate Adjustments | -0.34 | -0.08 | -0.07 | 0.07 | -0.01 | |
| Net Cash Flow | 11.59 | -9.37 | -15.4 | 41.2 | -7.11 | |
| Free Cash Flow | -58.51 | -33.38 | -34.46 | -37.86 | -22.12 | |
| Free Cash Flow Margin | -29.68% | -22.74% | -15.30% | -25.91% | -32.93% | |
| Free Cash Flow Per Share | -0.71 | -0.43 | -0.47 | -0.53 | -0.41 | |
| Cash Income Tax Paid | 0.09 | - | 0.02 | - | - | |
| Levered Free Cash Flow | -26.98 | -28.89 | -11.67 | -18.34 | - | |
| Unlevered Free Cash Flow | -26.98 | -28.89 | -11.67 | -18.34 | - | |
| Change in Working Capital | -9.08 | -3.01 | -6.74 | -0.02 | -2.56 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.